Showing results (141-150 of 880) with videos related to
Sort By:
Pageof 88
Diabetes Care|August 5, 2009
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trialSophia Zoungas, Bastiaan E de Galan, Toshiharu Ninomiya, et al.BMC Nephrology|June 19, 2012
Mortality in dialysis patients may not be associated with ESA dose: a 2-year prospective observational studyLawrence P McMahon, Michael X Cai, Sanjeev Baweja, et al.Nephrology (Carlton, Vic.)|May 18, 2016
Chronic kidney disease in Asia: Protocol for a collaborative overviewThaminda Liyanage, Toshiharu Ninomiya, Vlado Perkovic, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 5, 2011
Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study)Mona Razavian, Emma L Heeley, Vlado Perkovic, et al.The Cochrane Database of Systematic Reviews|January 29, 2014
HMG CoA reductase inhibitors (statins) for kidney transplant recipientsSuetonia C Palmer, Sankar D Navaneethan, Jonathan C Craig, et al.Journal of the American Society of Nephrology : JASN|December 13, 2023
Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE)Pablo E Pergola, Michael Davidson, Camilla Jensen, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 25, 2015
Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical TrialsXinfang Xie, Youxia Liu, Vlado Perkovic, et al.Plos One|September 11, 2015
Relationship between Serum Uric Acid Levels and Chronic Kidney Disease in a Japanese Cohort with Normal or Mildly Reduced Kidney FunctionTadashi Toyama, Kengo Furuichi, Miho Shimizu, et al.Presse Medicale (Paris, France : 1983)|December 24, 2022
Benefits of intensified reductions in blood glucose and in blood pressure for patients with type 2 diabetesNelson Wang, Sophia Zoungas, John ChalmersClinical and Experimental Pharmacology & Physiology|March 1, 2008
Advances in reducing the burden of vascular disease in type 2 diabetesJohn Chalmers, Rohina Joshi, Anushka PatelPageof 88